Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.690
+0.150 (9.74%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $100.50 million as of December 20, 2024. Its market cap has increased by 9.05% in one year.
Market Cap
100.50M
Enterprise Value
-23.78M
1-Year Change
9.05%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $100.50M, a decrease of -80.81%. That is a compound annual growth rate of -40.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 100.50M | 26.02% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 95.95M |
| Harvard Bioscience | 92.89M |
| bluebird bio | 92.75M |
| Century Therapeutics | 91.41M |
| Zentek | 91.34M |
| Nuvectis Pharma | 89.84M |
| HilleVax | 89.72M |
| LENSAR | 89.43M |